Clinical trial
hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure
NCT00008801 · National Center for Research Resources (NCRR), NIH · Unknown status
Key facts
| NCT number | NCT00008801 |
|---|---|
| Title | hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure |
| Official title | hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | Juvenile Diabetes Research Foundation |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Insulin-Dependent, Experimental, Transplantation, Homologous, Islets of Langerhans Transplantation |
| Intervention type | Drug |
| Interventions | hOKT3gamma1 (Ala-ala) |
| First posted | Jan 18, 2001 |
| Last update posted | Nov 1, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: